Drug Type Chemical drugs |
Synonyms Danaparoid sodium (JAN/USAN), 达那肝素钠, KB-101 + [4] |
Target |
Mechanism factor Xa inhibitors(Factor Xa inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date NL (01 Jan 1991), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03644 | Danaparoid Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Disseminated Intravascular Coagulation | JP | 20 Apr 2001 | |
Venous Thrombosis | US | 24 Dec 1996 | |
Thromboembolism | NL | 10 Jun 1991 | |
Thrombocytopenia | NL | - | 01 Jan 1991 |
Venous Thromboembolism | NL | - | 01 Jan 1991 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heparin-induced thrombocytopenia | Phase 3 | US | 16 May 2019 | |
Heparin-induced thrombocytopenia | Phase 3 | BA | 16 May 2019 | |
Heparin-induced thrombocytopenia | Phase 3 | CA | 16 May 2019 | |
Heparin-induced thrombocytopenia | Phase 3 | FR | 16 May 2019 | |
Heparin-induced thrombocytopenia | Phase 3 | DE | 16 May 2019 | |
Heparin-induced thrombocytopenia | Phase 3 | IT | 16 May 2019 | |
Heparin-induced thrombocytopenia | Phase 3 | PL | 16 May 2019 | |
Heparin-induced thrombocytopenia | Phase 3 | RU | 16 May 2019 | |
Heparin-induced thrombocytopenia | Phase 3 | RS | 16 May 2019 | |
Stroke | Phase 3 | US | 31 Dec 1995 |
GlobeNewswire Manual | Not Applicable | 233 | (adults patients) | qwzlnzhsef(jzscutzffx) = uzqxqyzjcm tdetccutpz (whyvrzjavh ) View more | Positive | 29 Aug 2024 | |
(pediatric patients) | qwzlnzhsef(jzscutzffx) = xseoivxeej tdetccutpz (whyvrzjavh ) View more |